Group 1 - The core point of the article is that Ying Sheng Science (00209) has completed a placement agreement, issuing a total of 30.95 million shares at a price of HKD 0.35 per share, which represents approximately 16.67% of the company's expanded issued share capital as of the announcement date [1][1][1] - On September 19, shareholders deposited shares into Imagi Brokerage Limited, with a market value of HKD 8.9759 million, accounting for 20% [1][1][1] - All conditions outlined in the placement agreement have been met, and the placement was completed according to the terms and conditions of the agreement [1][1][1]

Group 1 - The core point of the article is that Ying Sheng Science has completed a placement agreement, issuing shares at a price of HKD 0.35 per share, which represents approximately 16.67% of the company's expanded issued share capital [1][1][1] Group 2 - On September 19, shareholders of Ying Sheng Science deposited shares into Imagi Brokerage Limited, with a total market value of HKD 8.9759 million, accounting for 20% [1][1][1] - The company has issued a total of 30.9515 million placement shares to no fewer than six subscribers [1][1][1]

Group 1 - The company Ying Sheng Science (00209.HK) announced the issuance of 30.95 million shares under a placement agreement, with an issue price of HKD 0.35 per share [1]

如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 | | 是 | | | | 證券代號 (如上市) 00209 | 說明 | | 根據一般授權配售新股份 | | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | | | 已發行股份（不包括庫存股份）變動 | | 庫存股份變動 | | | | | | 事件 | 已發行股份（不包括庫存股份）數 目 | | 佔有關事件前的現有已發 行股份（不包括庫存股 份）數目百分比 (註3) | 庫存股份數目 | | 每股發行/出售價 (註4) | 已發行股份總數 | | | 於下列 ...

Core Viewpoint - The company, Ying Sheng Science (00209), has successfully completed a placement agreement, issuing a total of 30.9515 million shares at a price of HKD 0.35 per share, which represents approximately 16.67% of the company's enlarged issued share capital as of the announcement date [1]. Group 1 - The placement agreement conditions have all been met, and the placement was completed on September 19, 2025 [1]. - The company issued shares to no fewer than six placees [1]. - The placement price per share was set at HKD 0.35 [1].

Group 1 - The core point of the article is that Ying Sheng Science (00209) has completed a placement agreement, issuing a total of 30.9515 million shares at a price of HKD 0.35 per share, which represents approximately 16.67% of the company's issued share capital after the placement [1] Group 2 - The placement was completed on September 19, 2025, and all conditions outlined in the placement agreement have been met [1] - The shares were allocated to no fewer than six subscribers [1]

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不負責，對其 準確性或完整性亦不發表任何聲明，並明確表示不會就本公告全部或任何部份內容而產 生或因依賴該等內容而引致之任何損失承擔任何責任。 本公告僅供參考用途，並不構成收購、購買或認購本公司任何證券之邀請或要約。 WINSHINE SCIENCE COMPANY LIMITED 209 完成根據一般授權配售新股份 配售代理 完成根據一般授權配售新股份 董事會欣然宣佈，配售協議所載的所有條件均已達成，且配售事項已於二零二五年九月 十九日根據配售協議的條款及條件完成（「完成」）。根據配售協議，本公司已按每股配售 股份0.35港元之配售價，向不少於六名承配人配發及發行合共30,951,496股配售股份，相 當於本公告日期本公司已發行股本（經配發及發行配售股份擴大後）約16.67%。 - 1 - * 所得款項用途 配售事項的所得款項總額為10,833,023.60港元，扣除費用及開支後，配售事項的所得款項 淨額約為10,320,000.00港元。配售事項所得款項淨額擬作以下用途：(i)約50%用於償還貸 款；(ii)約10%用於支付未清償核數費用；(i ...

Group 1 - The core point of the article is that Ying Sheng Science (00209) has engaged in a share placement agreement, raising approximately HKD 10.83 million through the issuance of new shares at a price of HKD 0.350 per share [1] - On September 16, shareholders transferred shares worth HKD 3.7261 million from Hope Securities to Bank of China (Hong Kong), representing 8.45% of the total shares [1] - The share placement involves issuing 30.9515 million new shares, which accounts for about 16.67% of the company's total issued shares post-placement [1] Group 2 - The estimated net proceeds from the placement, after deducting all related expenses, are approximately HKD 10.32 million [1] - The company plans to allocate around 50% of the net proceeds for loan repayment and the other 50% for operational funds and general corporate purposes [1]

Core Viewpoint - The recent stock transfer and placement agreement of Ying Sheng Science indicates significant financial activities and capital restructuring within the company, highlighting its strategic focus on debt repayment and operational funding [1] Group 1: Stock Transfer - On September 16, shareholders of Ying Sheng Science transferred shares from Hope Securities to Bank of China (Hong Kong), with a market value of HKD 3.7261 million, accounting for 8.45% of the total shares [1] Group 2: Placement Agreement - On September 11, Ying Sheng Science announced a placement agreement with a placement agent, agreeing to place 30.9515 million new shares at a price of HKD 0.350 per share, representing approximately 16.67% of the enlarged issued share capital post-placement [1] - The total nominal value of the placement shares will be HKD 309,500 [1] - The total proceeds from the placement are estimated to be HKD 10.833 million, with a net amount of approximately HKD 10.32 million after deducting all related expenses [1] Group 3: Use of Proceeds - Approximately 50% of the net proceeds from the placement is intended for loan repayment, while the other 50% is earmarked for the group's working capital and general corporate purposes [1]

瀛晟科学宣布，将按每股0.350港元的价格配售3095.15万股新股份，占配售扩大后总股本的约16.67%。 配售所得款项总额为1083.3万港元，净额约1032万港元，其中约50%将用于偿还贷款，其余用于集团营 运资金及一般企业用途。 ...